Literature DB >> 15482572

Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.

Vishwa Jeet Amatya1, Yukio Takeshima, Mayumi Kaneko, Kouki Inai.   

Abstract

Carcinosarcoma of the esophagus is a rare tumor with a distinct pathological entity having squamous cell carcinoma as the most described carcinomatous component. This paper reports the first case of carcinosarcoma of the esophagus that showed predominant basaloid squamous carcinoma component in addition to squamous cell carcinoma and poorly differentiated carcinoma and sarcoma component. A 64-year-old male patient consulted for dysphasia and chest pain was examined and found to have gastrointestinal fiber-endoscope and a polypoid growth in the lower third of the esophagus. Partial esophagectomy was performed and the excised tumor showed histological features of carcinosarcoma with heterogeneous carcinomatous components with dominance of basaloid squamous carcinoma and minority of squamous cell carcinoma, poorly differentiated carcinoma, and sarcomatous component, immunohistochemically proven to be rhabdomyosarcoma. Immunohistochemical study and TP53 mutation analysis was carried out to explain the histogenesis of this rare tumor. The distinct immunohistochemical profiles of the carcinomatous and sarcomatous components suggested the possibility of transition from a carcinomatous to a sarcomatous component. The similar TP53 mutation in the carcinomatous and sarcomatous component suggested each of these components had the same origin, that is, the tumor was monoclonal in origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482572     DOI: 10.1111/j.1440-1827.2004.01759.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

1.  Synchronous oesophageal and gastric sarcomatoid carcinoma: first reported case in Australia.

Authors:  Puraskar Pateria; Niroshan Muwanwella; Ming Chai; Kannan Venugopal
Journal:  BMJ Case Rep       Date:  2018-05-26

2.  Spindle cell carcinoma of the esophagus: A multicenter analysis in comparison with typical squamous cell carcinoma.

Authors:  Baihua Zhang; Qin Xiao; Desong Yang; Xu Li; Jun Hu; Yonggang Wang; Wenxiang Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

3.  MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation.

Authors:  Michal Kunc; Anna Gabrych; Bartlomiej Rekawiecki; Adam Gorczynski; Sabine Franke; Johannes Haybaeck; Wojciech Biernat; Piotr Czapiewski
Journal:  Contemp Oncol (Pozn)       Date:  2019-11-07

4.  Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case.

Authors:  Shinichiro Kobayashi; Yasuhiro Nagata; Hirotaka Tokai; Masahiro Ito; Hikaru Fujioka
Journal:  Clin Case Rep       Date:  2015-06-18

5.  The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma.

Authors:  Xin Min Li; Xin Song; Xue Ke Zhao; Shou Jia Hu; Rang Cheng; Shuang Lv; Dan Feng Du; Xiang Yang Zhang; Jian Liang Lu; Jian Wei Ku; Dong Yun Zhang; Yao Zhang; Zong Min Fan; Li Dong Wang
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430

6.  Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma.

Authors:  Michał Kunc; Anna Gabrych; Bartłomiej Rękawiecki; Adam Gorczyński; Johannes Haybaeck; Wojciech Biernat; Piotr Czapiewski
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.